A Phase 2 trial of Veverimer
Latest Information Update: 26 Feb 2024
At a glance
- Drugs Veverimer (Primary)
- Indications Unspecified
- Focus Therapeutic Use
- 26 Feb 2024 New trial record
- 22 Feb 2024 According to a Renibus Therapeutics media release, company analyzing historical data to further understanding of its clinical profile with a goal of identifying an indication for evaluation in a phase II trial.